BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27233940)

  • 1. Lobular breast cancer: Clinical, molecular and morphological characteristics.
    Christgen M; Steinemann D; Kühnle E; Länger F; Gluz O; Harbeck N; Kreipe H
    Pathol Res Pract; 2016 Jul; 212(7):583-97. PubMed ID: 27233940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
    Christgen M; Bruchhardt H; Hadamitzky C; Rudolph C; Steinemann D; Gadzicki D; Hasemeier B; Römermann D; Focken T; Krech T; Ballmaier M; Schlegelberger B; Kreipe H; Lehmann U
    J Pathol; 2009 Apr; 217(5):620-32. PubMed ID: 19191266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?
    Karch I; Schipper E; Christgen H; Kreipe H; Lehmann U; Christgen M
    PLoS One; 2013; 8(8):e73062. PubMed ID: 24023670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.
    Forster-Sack M; Zoche M; Pestalozzi B; Witzel I; Schwarz EI; Herzig JJ; Fansa H; Tausch C; Ross J; Moch H; Varga Z
    J Pathol Clin Res; 2024 Mar; 10(2):e12362. PubMed ID: 38335502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic PIK3CA mutations in lobular breast cancer progression.
    Christgen M; Noskowicz M; Schipper E; Christgen H; Heil C; Krech T; Länger F; Kreipe H; Lehmann U
    Genes Chromosomes Cancer; 2013 Jan; 52(1):69-80. PubMed ID: 22997091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Characterization of Primary Invasive Lobular Breast Cancer.
    Desmedt C; Zoppoli G; Gundem G; Pruneri G; Larsimont D; Fornili M; Fumagalli D; Brown D; Rothé F; Vincent D; Kheddoumi N; Rouas G; Majjaj S; Brohée S; Van Loo P; Maisonneuve P; Salgado R; Van Brussel T; Lambrechts D; Bose R; Metzger O; Galant C; Bertucci F; Piccart-Gebhart M; Viale G; Biganzoli E; Campbell PJ; Sotiriou C
    J Clin Oncol; 2016 Jun; 34(16):1872-81. PubMed ID: 26926684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tubulolobular carcinoma of breast: a clinicopathologic study of 8 cases].
    Shi J; Liang ZY; Meng ZL; Luo YF; Cao JL; Yang CM; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):681-5. PubMed ID: 23302310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements.
    Christgen M; Bartels S; van Luttikhuizen JL; Bublitz J; Rieger LU; Christgen H; Stark H; Sander B; Lehmann U; Steinemann D; Derksen PWB; Kreipe H
    Mod Pathol; 2020 Dec; 33(12):2483-2498. PubMed ID: 32572153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS; Kestin LL; Vicini FA
    Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lobular neoplasia and invasive lobular breast cancer: Inter-observer agreement for histological grading and subclassification.
    Schaumann N; Raap M; Hinze L; Rieger L; Schürch CM; Antonopoulos W; Avril S; Krech T; Dämmrich M; Kayser G; Puls F; Länger F; Tinguely M; Kreipe H; Christgen M
    Pathol Res Pract; 2019 Nov; 215(11):152611. PubMed ID: 31551174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular breast cancer--the most common special subtype or a most special common subtype?
    Lehmann U
    Breast Cancer Res; 2015 Jul; 17(1):99. PubMed ID: 26215581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics.
    McCart Reed AE; Kutasovic JR; Lakhani SR; Simpson PT
    Breast Cancer Res; 2015 Jan; 17(1):12. PubMed ID: 25849106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of lobular breast cancer in distant metastases to the orbit.
    Raap M; Antonopoulos W; Dämmrich M; Christgen H; Steinmann D; Länger F; Lehmann U; Kreipe H; Christgen M
    Cancer Med; 2015 Jan; 4(1):104-11. PubMed ID: 25355547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
    Sadek BT; Shenouda MN; Abi Raad RF; Niemierko A; Keruakous AR; Goldberg SI; Taghian AG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):726-30. PubMed ID: 24064317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical margins in breast-conservation operations for invasive carcinoma: does neoadjuvant chemotherapy have an impact?
    Soucy G; Bélanger J; Leblanc G; Sideris L; Drolet P; Mitchell A; Leclerc YE; Dufresne MP; Beaudet J; Dubé P
    J Am Coll Surg; 2008 Jun; 206(6):1116-21. PubMed ID: 18501808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance].
    Ma YH; Wang K; Li L; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):5-9. PubMed ID: 20388391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second operation more frequent following breast-conserving treatment for invasive lobular than for invasive non-lobular carcinoma].
    de Zeeuw S; Wildenberg F; Strobbe L; Wobbes T
    Ned Tijdschr Geneeskd; 2009; 153():A56. PubMed ID: 19900317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.